Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

Respirology

Volumn 16, Issue 8, 2011, Pages 1196-1202

  Kozu, Ryo ^a,c,d   Jenkins, Sue ^c,d,e   Senjyu, Hideaki ^b  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

dyspnoea; exercise; idiopathic pulmonary fibrosis; rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISABILITY SEVERITY; DISEASE EXACERBATION; DYSPNEA; EXERCISE; FEMALE; FIBROSING ALVEOLITIS; FUNCTIONAL STATUS; HEALTH STATUS; HOME REHABILITATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOME STUDY SHORT FORM 36; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY REHABILITATION; TRANSITION DYSPNEA INDEX;

AGED; DISABILITY EVALUATION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80155202722     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02029.x     Document Type: Article

References (41)

1. Swigris JJ, Brown KK, Make BJ, et al,. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir. Med. 2008; 102: 1675-80.
2. Holland AE, Hill CJ, Conron M, et al,. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549-54. (Pubitemid 351831168)
3. Nishiyama O, Kondoh Y, Kimura T, et al,. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008; 13: 394-9. (Pubitemid 351503129)
4. Holland A, Hill C,. Physical training for interstitial lung disease. Cochrane Database Syst. Rev. 2008; (4): CD006322.
5. Kozu R, Senjyu H, Jenkins SC, et al,. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration 2011; 81: 196-205.
6. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646-64.
7. Fletcher CM, Elmes PC, Fairbairn AS, et al,. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br. Med. J. 1959; 2: 257-66.
8. Kozu R, Jenkins S, Senjyu H, et al,. Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respirology 2010; 15: 706-13.
9. Miller MR, Hankinson J, Brusasco V, et al,. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-38. (Pubitemid 41079078)
10. Macintyre N, Crapo RO, Viegi G, et al,. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005; 26: 720-35. (Pubitemid 41448672)
11. Fukuhara S, Bito S, Green J, et al,. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J. Clin. Epidemiol. 1998; 51: 1037-44. (Pubitemid 28527159)
12. Crapo RO, Casaburi R, Coates AL, et al,. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-17. (Pubitemid 34693972)
13. Weisman I, Beck KC, Casaburi R, et al,. ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211-77.
14. Borg GA,. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982; 14: 377-81. (Pubitemid 13215050)
15. Mahler DA, Weinberg DH, Wells CK, et al,. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-8. (Pubitemid 14121920)
16. Spector WD, Katz S, Murphy JB, et al,. The hierarchical relationship between activities of daily living and instrumental activities of daily living. J. Chronic Dis. 1987; 40: 481-9. (Pubitemid 17084794)
17. Sabit R, Griffiths TL, Watkins AJ, et al,. Predictors of poor attendance at an outpatient pulmonary rehabilitation programme. Respir. Med. 2008; 102: 819-24.
18. Lachin JM,. Statistical considerations in the intent-to-treat principle. Control. Clin. Trials 2000; 21: 167-89. (Pubitemid 30259147)
19. Holland AE, Hill CJ, Conron M, et al,. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir. Med. 2009; 103: 1430-5.
20. Swigris JJ, Brown KK, Behr J, et al,. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir. Med. 2010; 104: 296-304.
21. Garrod R, Marshall J, Barley E, et al,. Predictors of success and failure in pulmonary rehabilitation. Eur. Respir. J. 2006; 27: 788-94. (Pubitemid 44914204)
22. Wedzicha JA, Bestall JC, Garrod R, et al,. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur. Respir. J. 1998; 12: 363-9. (Pubitemid 28389530)
23. Evans RA, Singh SJ, Collier R, et al,. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir. Med. 2009; 103: 1070-5.
24. Collard HR, Moore BB, Flaherty KR, et al,. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636-43. (Pubitemid 47503070)
25. Martinez FJ, Safrin S, Weycker D, et al,. The clinical course of patients with idiopathic pulmonary fibrosis. Ann. Intern. Med. 2005; 142: 963-7.
26. Collard HR, King TE Jr, Bartelson BB, et al,. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 538-42. (Pubitemid 37088595)
27. Flaherty KR, Mumford JA, Murray S, et al,. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003; 168: 543-8. (Pubitemid 37088596)
28. Bjoraker JA, Ryu JH, Edwin MK, et al,. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1998; 157: 199-203. (Pubitemid 28071283)
29. Manali ED, Stathopoulos GT, Kollintza A, et al,. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respir. Med. 2008; 102: 586-92.
30. Barry SC, Gallagher CG,. Corticosteroids and skeletal muscle function in cystic fibrosis. J. Appl. Physiol. 2003; 95: 1379-84. (Pubitemid 37169279)
31. Spruit MA, Thomeer MJ, Gosselink R, et al,. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32-8. (Pubitemid 40101015)
32. Ferreira A, Garvey C, Connors GL, et al,. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442-7.
33. Griffiths TL, Burr ML, Campbell IA, et al,. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355: 362-8.
34. Foglio K, Bianchi L, Ambrosino N,. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest 2001; 119: 1696-704. (Pubitemid 32744924)
35. Cecins N, Geelhoed E, Jenkins SC,. Reduction in hospitalisation following pulmonary rehabilitation in patients with COPD. Aust. Health Rev. 2008; 32: 415-22.
36. Decramer M, Gosselink R, Troosters T, et al,. Muscle weakness is related to utilization of health care resources in COPD patients. Eur. Respir. J. 1997; 10: 417-23. (Pubitemid 27063862)
37. Garcia-Aymerich J, Farrero E, Felez MA, et al,. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-5. (Pubitemid 36182995)
38. Garcia-Aymerich J, Lange P, Benet M, et al,. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-8. (Pubitemid 44369401)
39. Bourbeau J, Julien M, Maltais F, et al,. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch. Intern. Med. 2003; 163: 585-91. (Pubitemid 36314346)
40. Harris-Eze AO, Sridhar G, Clemens RE, et al,. Oxygen improves maximal exercise performance in interstitial lung disease. Am. J. Respir. Crit. Care Med. 1994; 150: 1616-22. (Pubitemid 24361736)
41. Neder JA, Sword D, Ward SA, et al,. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-7. (Pubitemid 34298931)